-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAVERE THERAPEUTICS, INC. : CANACCORD GENUITY RAISES TARGET PRICE TO $70 FROM $62

Reuters·08/05/2026 13:16:22

Please log in to view news